Investing
-
How Should We Think About Misinformation?
David Inserra A recent Guardian article argued that “rampant climate misinformation is turning the crisis into a catastrophe” and favorably…
Read More » -
Fossil Fuel Subsidies Are Mostly Fiction, But the Real Energy Subsidies Should Go
Adam N. Michel You’ve probably heard the claim that fossil fuels are heavily subsidized by the federal government. The Biden…
Read More » -
Overlicensed and Underused: Rethinking Pharmacy’s Role in Health Care
Jeffrey A. Singer The American Society of Hospital Pharmacists (ASHP) launched its Practice Advancement Initiative (PAI) in 2010 and updated…
Read More » -
Warren, Trump, and the Debt Limit
Jeffrey Miron In a rare twist, Elizabeth Warren and Donald Trump agree on one thing: the United States should repeal the federal…
Read More » -
Ending the US Department of Education: Status Report
Neal McCluskey About three months ago, President Donald Trump issued an executive order calling on the US Secretary of Education…
Read More » -
The Safety Risks of the Coming AI Regulatory Patchwork
Matt Mittelsteadt In recent weeks, the specifics of Congress’s proposed state AI regulatory moratorium have dominated AI policy discussions. Because…
Read More » -
ICE Is Arresting 1,100 Percent More Noncriminals on the Streets Than in 2017
David J. Bier Last week, the Cato Institute published new, nonpublic data showing that Immigration and Customs Enforcement (ICE) is…
Read More » -
ICE Is Arresting 1,300 Percent More Noncriminals on the Streets Than in 2017
David J. Bier Last week, the Cato Institute published new, nonpublic data showing that Immigration and Customs Enforcement (ICE) is…
Read More » -
Punishing Universities for Their Viewpoints Violates the First Amendment
Thomas A. Berry The Trump administration has taken actions to withhold billions of dollars in contracts from Harvard University unless…
Read More » -
The FDA’s Biosimilar Burden—and How Congress Can Lift It
Jeffrey A. Singer In recent testimony before the Senate Appropriations Committee, Food and Drug Administration Commissioner Marty A. Makary, MD,…
Read More »